解剖学报 ›› 2017, Vol. 48 ›› Issue (6): 635-641.doi: 10.16098/j.issn.0529-1356.2017.06.001

• 神经生物学 •    下一篇

脑内移植RMNE6细胞治疗缺血性脑损伤的效果

武赟1,2* 翟晓艳1 杨李旺1 徐群渊2   

  1. 1. 山西中医药大学基础医学院解剖学教研室,山西 晋中 030619;2.首都医科大学神经生物学系,北京 100069
  • 收稿日期:2016-12-30 修回日期:2017-02-24 出版日期:2017-12-06 发布日期:2017-12-06
  • 通讯作者: 武赟 E-mail:wu_yun19741981@163.com
  • 基金资助:
    促血管神经发生水凝胶载体与神经干细胞联合移植治疗小鼠脑梗塞模型的实验研究

Effects of intracerebral transplantation of RMNE6 on the ischemic injury of the brain

 WU Yun 1,2* ZHAI Xiao-yan1 YANG Li-wang1 XU Qun-yuan2   

  1. 1.Department of Anatomy, Basic Medical College, Shanxi University of Chinese Medicine,Shanxi Jinzhong 030619, China;2.Department of Neurobiology, Capital Medical University, Beijing 100069, Chnia
  • Received:2016-12-30 Revised:2017-02-24 Online:2017-12-06 Published:2017-12-06
  • Contact: WU Yun E-mail:wu_yun19741981@163.com

摘要:

目的 为细胞替代治疗缺血性脑损伤选择合适的干细胞。 方法 将RMNE6细胞植入正常脑和缺血模型大鼠脑(8只)内,通过免疫荧光染色、行为学实验、影像学等方法观察其在脑内的状况,与安慰剂组(8只)及成纤维细胞移植组(8只)比较,观察其对模型动物梗塞体积的影响和模型动物行为学的改善。 结果 细胞移植后,RMNE6细胞在正常脑和缺血脑内可以存活,但移植有RMNE6细胞的缺血脑内出现肿瘤。细胞移植与否对梗死体积没有影响。细胞移植后,模型动物的行为学也未见明显改善。 结论 从安全性的角度考虑,RMNE6细胞不适合通过脑内移植治疗缺血性脑损伤,RMNE6细胞还需要改造。

关键词: RMNE6细胞, 细胞移植, 脑缺血, 免疫荧光, 磁共振成像, 大鼠

Abstract:

Objective To select the suitable stem cells for cell replacement in stroke therapy. Methods The RMNE6 cells were transplanted into the normal brain and injured brain of the stroke model of rats (n=8). The fates of the RMNE6 cells in the normal brain and the injured brain, the effects on the ischemic volume and the improvements on the behavior of the rats were observed by immunofluorescence staining, behaviour testing and magnetic resonance imaging, compared with the placebo group (n=8) and the fibroblast group (n=8). Results After transplantation, the RMNE6 cells were able to survive in the normal and ischemic brain area. There was tumourigenesis in the ischemic brain transplanted with the RMNE6 cells. The cell transplantation had no effects on the size of the ischemic volume. The behavior of the model animals had no significiant improvement. Conclusion As far as the safety is concerned, the RMNE6 cells are not suitable for cell replacement in the stroke therapy and still need to be modified.

Key words: RMNE6 cell, Cell transplantation, Brain ischemia, Immunofluorescence, Magnetic resonance imaging, Rat